57 research outputs found

    Strong-coupling limit of depleted Kondo- and Anderson-lattice models

    Full text link
    Fourth-order strong-coupling degenerate perturbation theory is used to derive an effective low-energy Hamiltonian for the Kondo-lattice model with a depleted system of localized spins. In the strong-J limit, completely local Kondo singlets are formed at the spinful sites which bind a fraction of conduction electrons. The low-energy theory describes the scattering of the excess conduction electrons at the Kondo singlets as well as their effective interactions generated by virtual excitations of the singlets. Besides the Hubbard term, already discussed by Nozieres, we find a ferromagnetic Heisenberg interaction, an antiferromagnetic isospin interaction, a correlated hopping and, in more than one dimensions, three- and four-site interactions. The interaction term can be cast into highly symmetric and formally simple spin-only form using the spin of the bonding orbital symmetrically centered around the Kondo singlet. This spin is non-local. We show that, depending on the geometry of the depleted lattice, spatial overlap of the non-local spins around different Kondo singlets may cause ferromagnetic order. This is sustained by a rigorous argument, applicable to the half-filled model, by a variational analysis of the stability of the fully polarized Fermi sea of excess conduction electrons as well as by exact diagonalization of the effective model. A similar fourth-order perturbative analysis is performed for the depleted Anderson lattice in the limit of strong hybridization. Even in a parameter regime where the Schrieffer-Wolff transformation does not apply, this yields the same effective theory albeit with a different coupling constant.Comment: 14 pages, 5 figure

    Competition between Kondo screening and indirect magnetic exchange in a quantum box

    Full text link
    Nanoscale systems of metal atoms antiferromagnetically exchange coupled to several magnetic impurities are shown to exhibit an unconventional re-entrant competition between Kondo screening and indirect magnetic exchange interaction. Depending on the atomic positions of the magnetic moments, the total ground-state spin deviates from predictions of standard Ruderman-Kittel-Kasuya-Yosida perturbation theory. The effect shows up on an energy scale larger than the level width induced by the coupling to the environment and is experimentally verifiable by studying magnetic field dependencies.Comment: 5 pages, 2 figures, v3 with minor change

    Dynamical mean-field theory of indirect magnetic exchange

    Full text link
    To analyze the physical properties arising from indirect magnetic exchange between several magnetic adatoms and between complex magnetic nanostructures on metallic surfaces, the real-space extension of dynamical mean-field theory (R-DMFT) appears attractive as it can be applied to systems of almost arbitrary geometry and complexity. While R-DMFT describes the Kondo effect of a single adatom exactly, indirect magnetic (RKKY) exchange is taken into account on an approximate level only. Here, we consider a simplified model system consisting of two magnetic Hubbard sites ("adatoms") hybridizing with a non-interacting tight-binding chain ("substrate surface"). This two-impurity Anderson model incorporates the competition between the Kondo effect and indirect exchange but is amenable to an exact numerical solution via the density-matrix renormalization group (DMRG). The particle-hole symmetric model at half-filling and zero temperature is used to benchmark R-DMFT results for the magnetic coupling between the two adatoms and for the magnetic properties induced in the substrate. In particular, the dependence of the local adatom and the nonlocal adatom-adatom static susceptibilities as well as the magnetic response of the substrate on the distance between the adatoms and on the strength of their coupling with the substrate is studied. We find both, excellent agreement with the DMRG data even on subtle details of the competition between RKKY exchange and the Kondo effect but also complete failure of the R-DMFT, depending on the parameter regime considered. R-DMFT calculations are performed using the Lanczos method as impurity solver. With the real-space extension of the two-site DMFT, we also benchmark a simplified R-DMFT variant.Comment: 14 pages, 8 figure

    Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction, GALACTIC‐HF: baseline characteristics and comparison with contemporary clinical trials

    Get PDF
    Aims: The safety and efficacy of the novel selective cardiac myosin activator, omecamtiv mecarbil, in patients with heart failure with reduced ejection fraction (HFrEF) is tested in the Global Approach to Lowering Adverse Cardiac outcomes Through Improving Contractility in Heart Failure (GALACTIC‐HF) trial. Here we describe the baseline characteristics of participants in GALACTIC‐HF and how these compare with other contemporary trials. Methods and Results: Adults with established HFrEF, New York Heart Association functional class (NYHA) ≥ II, EF ≤35%, elevated natriuretic peptides and either current hospitalization for HF or history of hospitalization/ emergency department visit for HF within a year were randomized to either placebo or omecamtiv mecarbil (pharmacokinetic‐guided dosing: 25, 37.5 or 50 mg bid). 8256 patients [male (79%), non‐white (22%), mean age 65 years] were enrolled with a mean EF 27%, ischemic etiology in 54%, NYHA II 53% and III/IV 47%, and median NT‐proBNP 1971 pg/mL. HF therapies at baseline were among the most effectively employed in contemporary HF trials. GALACTIC‐HF randomized patients representative of recent HF registries and trials with substantial numbers of patients also having characteristics understudied in previous trials including more from North America (n = 1386), enrolled as inpatients (n = 2084), systolic blood pressure < 100 mmHg (n = 1127), estimated glomerular filtration rate < 30 mL/min/1.73 m2 (n = 528), and treated with sacubitril‐valsartan at baseline (n = 1594). Conclusions: GALACTIC‐HF enrolled a well‐treated, high‐risk population from both inpatient and outpatient settings, which will provide a definitive evaluation of the efficacy and safety of this novel therapy, as well as informing its potential future implementation
    corecore